- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 389 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 486 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 197 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 192 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 387 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 387 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 149 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 169 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 379 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 269 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 199 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 285 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 265 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 268 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 287 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 283 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 369 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 478 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 434 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more